The AJMC® Pulmonary Arterial Hypertension compendium is a comprehensive resource for clinical news and expert insights for the progressive disorder, which is characterized by high blood pressure in the arteries that go from the heart to the lungs.
June 27th 2025
Previous knowledge on melatonin use for pulmonary arterial hypertension has primarily been gathered from animal studies, with oxidative stress implicated in the disease’s progression and severity.
Advancements Needed in Research on SCD-Associated Pulmonary Hypertension
Personalized Medicine Would Offer Great Benefits to Patients With PAH